Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women

Detalhes bibliográficos
Autor(a) principal: Sarmento, Ayane Cristine
Data de Publicação: 2020
Outros Autores: Fernandes, Fabíola Sephora, Marconi, Camila, Giraldo, Paulo César, Eleutério-Júnior, José, Crispim, Janaina C., Gonçalves, Ana Katherine
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/173662
Resumo: OBJECTIVES: We aimed to evaluate the effectiveness of microablative fractional radiofrequency (MAFRF) in the non-hormonal treatment of genitourinary syndrome of menopause. METHODS: We examined the cases of 55 postmenopausal women before and after treatment with regard to their vaginal health index (VHI), vaginal microbiota, vaginal pH, and cell maturation. Three applications of MAFRF were performed in the vagina/vaginal introitus. During the treatment, six vaginal smears were obtained and stained with the Papanicolaou stain for determining the degree of cell maturation and with Gram stain for classification of vaginal flora, as per the criteria of Spiegel and Amsel. For vaginal pH determination, pH indicator strips were applied against the vaginal wall. Statistical analysis was performed using SPSS for Windows (version 17.0). Data were reported as mean±standard deviation. The differences were analyzed using the statistical method of generalized estimation equations with autoregressive correlation structure ‘‘1’’ and robust standard errors. RESULTS: The mean age was 59.8±4.2 years, and the mean time of menopause was 15.4±4.5 years. After treatment, there was an increase in the percentage of Lactobacillus spp. (po0.001). Consequently, there was a progressive decrease in vaginal pH during the treatment (po0.001). Regarding cell maturation, there was a decrease in the percentage of parabasal cells (p=0.001) and an increase in the rate of superficial cells (po0.001). Additionally, there was an improvement in the VHI index. The mean VHI values before and after treatment were 13.2±5.6 and 22.5±3.7, respectively (po0.001). CONCLUSION: MAFRF treatment is well tolerated and leads to improvement in the vaginal microenvironment.
id USP-19_6e314f1d4cd8c994dd55cf711ee5cb25
oai_identifier_str oai:revistas.usp.br:article/173662
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal womenMenopauseRadiofrequencyDyspareuniaOrgasmTherapeuticsOBJECTIVES: We aimed to evaluate the effectiveness of microablative fractional radiofrequency (MAFRF) in the non-hormonal treatment of genitourinary syndrome of menopause. METHODS: We examined the cases of 55 postmenopausal women before and after treatment with regard to their vaginal health index (VHI), vaginal microbiota, vaginal pH, and cell maturation. Three applications of MAFRF were performed in the vagina/vaginal introitus. During the treatment, six vaginal smears were obtained and stained with the Papanicolaou stain for determining the degree of cell maturation and with Gram stain for classification of vaginal flora, as per the criteria of Spiegel and Amsel. For vaginal pH determination, pH indicator strips were applied against the vaginal wall. Statistical analysis was performed using SPSS for Windows (version 17.0). Data were reported as mean±standard deviation. The differences were analyzed using the statistical method of generalized estimation equations with autoregressive correlation structure ‘‘1’’ and robust standard errors. RESULTS: The mean age was 59.8±4.2 years, and the mean time of menopause was 15.4±4.5 years. After treatment, there was an increase in the percentage of Lactobacillus spp. (po0.001). Consequently, there was a progressive decrease in vaginal pH during the treatment (po0.001). Regarding cell maturation, there was a decrease in the percentage of parabasal cells (p=0.001) and an increase in the rate of superficial cells (po0.001). Additionally, there was an improvement in the VHI index. The mean VHI values before and after treatment were 13.2±5.6 and 22.5±3.7, respectively (po0.001). CONCLUSION: MAFRF treatment is well tolerated and leads to improvement in the vaginal microenvironment.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2020-08-14info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://www.revistas.usp.br/clinics/article/view/17366210.6061/clinics/2020/e1750Clinics; Vol. 75 (2020); e1750Clinics; v. 75 (2020); e1750Clinics; Vol. 75 (2020); e17501980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/173662/162766https://www.revistas.usp.br/clinics/article/view/173662/162767Copyright (c) 2020 Clinicsinfo:eu-repo/semantics/openAccessSarmento, Ayane CristineFernandes, Fabíola SephoraMarconi, CamilaGiraldo, Paulo CésarEleutério-Júnior, JoséCrispim, Janaina C.Gonçalves, Ana Katherine2020-08-14T21:51:04Zoai:revistas.usp.br:article/173662Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2020-08-14T21:51:04Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women
title Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women
spellingShingle Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women
Sarmento, Ayane Cristine
Menopause
Radiofrequency
Dyspareunia
Orgasm
Therapeutics
title_short Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women
title_full Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women
title_fullStr Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women
title_full_unstemmed Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women
title_sort Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women
author Sarmento, Ayane Cristine
author_facet Sarmento, Ayane Cristine
Fernandes, Fabíola Sephora
Marconi, Camila
Giraldo, Paulo César
Eleutério-Júnior, José
Crispim, Janaina C.
Gonçalves, Ana Katherine
author_role author
author2 Fernandes, Fabíola Sephora
Marconi, Camila
Giraldo, Paulo César
Eleutério-Júnior, José
Crispim, Janaina C.
Gonçalves, Ana Katherine
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sarmento, Ayane Cristine
Fernandes, Fabíola Sephora
Marconi, Camila
Giraldo, Paulo César
Eleutério-Júnior, José
Crispim, Janaina C.
Gonçalves, Ana Katherine
dc.subject.por.fl_str_mv Menopause
Radiofrequency
Dyspareunia
Orgasm
Therapeutics
topic Menopause
Radiofrequency
Dyspareunia
Orgasm
Therapeutics
description OBJECTIVES: We aimed to evaluate the effectiveness of microablative fractional radiofrequency (MAFRF) in the non-hormonal treatment of genitourinary syndrome of menopause. METHODS: We examined the cases of 55 postmenopausal women before and after treatment with regard to their vaginal health index (VHI), vaginal microbiota, vaginal pH, and cell maturation. Three applications of MAFRF were performed in the vagina/vaginal introitus. During the treatment, six vaginal smears were obtained and stained with the Papanicolaou stain for determining the degree of cell maturation and with Gram stain for classification of vaginal flora, as per the criteria of Spiegel and Amsel. For vaginal pH determination, pH indicator strips were applied against the vaginal wall. Statistical analysis was performed using SPSS for Windows (version 17.0). Data were reported as mean±standard deviation. The differences were analyzed using the statistical method of generalized estimation equations with autoregressive correlation structure ‘‘1’’ and robust standard errors. RESULTS: The mean age was 59.8±4.2 years, and the mean time of menopause was 15.4±4.5 years. After treatment, there was an increase in the percentage of Lactobacillus spp. (po0.001). Consequently, there was a progressive decrease in vaginal pH during the treatment (po0.001). Regarding cell maturation, there was a decrease in the percentage of parabasal cells (p=0.001) and an increase in the rate of superficial cells (po0.001). Additionally, there was an improvement in the VHI index. The mean VHI values before and after treatment were 13.2±5.6 and 22.5±3.7, respectively (po0.001). CONCLUSION: MAFRF treatment is well tolerated and leads to improvement in the vaginal microenvironment.
publishDate 2020
dc.date.none.fl_str_mv 2020-08-14
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/173662
10.6061/clinics/2020/e1750
url https://www.revistas.usp.br/clinics/article/view/173662
identifier_str_mv 10.6061/clinics/2020/e1750
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/173662/162766
https://www.revistas.usp.br/clinics/article/view/173662/162767
dc.rights.driver.fl_str_mv Copyright (c) 2020 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/xml
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 75 (2020); e1750
Clinics; v. 75 (2020); e1750
Clinics; Vol. 75 (2020); e1750
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222765184188416